Drug Trial Radar · NCT02886715
A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris
Last checked: Nov 19, 2026Latest source record: Aug 17, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,110
Actual
Start
Sep 21, 2016
Primary completion
May 31, 2017
Study completion May 31, 2017
Sponsor
- Lead sponsor
- Fougera Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 1, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris
Conditions
- Acne Vulgaris
Interventions
Tazarotene Cream 0.1%Drug
Tazarotene Cream 0.1% applied to cover the affected areas of the face once daily for 84 +/- 4 days.
Tazorac®Drug
Tazorac® applied to cover the affected areas of the face once daily for 84 +/- 4 days.
PlaceboDrug
Placebo (vehicle of the test product) applied to cover the affected areas of the face once daily for 84 +/- 4 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Inflammatory Lesion CountsTime frame: Week 12
- Change in Non-inflammatory Lesion CountsTime frame: Week 12
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Fougera Investigational Site
Tucson, Arizona
Fougera Investigational Site
Conway, Arkansas
Fougera Investigational Site
Hot Springs, Arkansas
Fougera Investigational Site
Anaheim, California
Fougera Investigational Site
La Mesa, California
Fougera Investigational Site
Long Beach, California
Fougera Investigational Site
Long Beach, California
Fougera Investigational Site
Los Angeles, California
Fougera Investigational Site
North Hollywood, California
Fougera Investigational Site
San Diego, California
Fougera Investigational Site
San Ramon, California
Fougera Investigational Site
Upland, California
Fougera Investigational Site
West Covina, California
Fougera Investigational Site
Coral Gables, Florida
Fougera Investigational Site
Miami, Florida
Fougera Investigational Site
Miami, Florida
Fougera Investigational Site
Miami Gardens, Florida
Fougera Investigational Site
Miramar, Florida
Fougera Investigational Site
Sweetwater, Florida
Fougera Investigational Site
Plainfield, Indiana
Fougera Investigational Site
High Point, North Carolina
Fougera Investigational Site
Hazleton, Pennsylvania
Fougera Investigational Site
Upper Saint Clair, Pennsylvania
Fougera Investigational Site
Chattanooga, Tennessee
Fougera Investigational Site
Austin, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.